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Abstract 
Background: Survival and colony formation by transplanted tissue derived connective tissue progenitor cells (CTPs) are 
thought to be important factors in the success of clinical tissue engineering strategies for bone regeneration. Transplantation 
of cells into defects larger than a few millimeters expose cells to a profoundly hypoxic environment. Tis study tested the 
hypothesis that delaying the onset of hypoxia will improve the survival and performance of CTPs in vitro. 
Methods: To mimic declines seen in an avascular in vivo bone defect, colony forming efciency by marrow derived nucleated 
cells was assessed under osteogenic conditions. Variation in the rate of oxygen decline from an oxygen tension of 21% to 0.1% 
oxygen was explored using an incubator with programmable active control of gas concentrations. Te efect of doping cultures 
with defned concentrations of RBCs was also used to evaluate the potential for RBCs to serve as a natural bufer in the setting 
of declining oxygen levels. 
Results: A delay in onset of hypoxia over 96 hours resulted in a 3-fold increase in the relative colony forming efciency (rCFE) 
of CTPs as compared to an immediate onset of hypoxia. Te presence of RBCs in vitro inhibited the rCFE of CTPs. Given the 
negative efects of RBCs, methods of RBC removal were evaluated and compared for their efectiveness of RBC removal and 
retention of colony forming efciency. 
Conclusions: Tese data suggest that conditions of hypoxia compromise colony forming efciency in marrow derived CTPs. 
However, slowing the rate of decline of oxygen preserved colony forming efciency at levels achieved in a stable normoxic (3% 
O2) environment. Tese data also suggest that RBCs are detrimental to the rCFE of CTPs and that bufy coat is an efective 
and preferred method for removing RBCs from marrow aspirates while preserving CTPs. Tese fndings may inform clinical 
strategies for CTP transplantation. 
Keywords: Progenitor cell, colony forming unit, bone marrow, cellular hypoxia, red blood cells, lymphoprep, blood bufy coat, 
cell therapy 
Introduction 
Connective Tissue Progenitor Cells (CTPs) are defined as the
heterogeneous population of stem and progenitor cells in
native tissues that are capable of giving rise to progeny that can
differentiate into one or more connective tissue phenotypes
[1,2]. They differ from mesenchymal stem cell populations in
that they are not culture expanded, and therefore are not a
homogenous population. They are distinctly heterogeneous in
their expression of cell surface proteins or any other unifying
genetic or protein signature. CTPs only require differentiation
down one connective tissue pathway rather than trilineage
differentiation (as is required in the definition of MSCs), to
be distinguished as a CTP. The harvest, processing, and
transplantation of CTPs and their progeny are central to many
therapy approaches that are designed to repair and regenerate
new tissues [3]. The efficacy of these approaches is dependent
upon the survival of transplanted cells. 
One of the greatest threats to survival of either local or
transplanted CTPs is the magnitude of hypoxia that develops in
a graft site and the rate of onset of hypoxia. In any graft site more
than a few millimeters in dimension, oxygen tension plummets
in the first 2 days following implantation [4]. Transplanted
cells and local inflammatory cells consume local oxygen at a
rate that is far faster than can be supported by diffusion until
the time that revascularization occurs and a system of mass
transport via convection is reestablished [2,4,5]. 
CTPs have relatively low prevalence in native tissues. In
healthy marrow aspirate, the prevalence is approximately
1 in 20,000 nucleated cells [2]. As a result, in bone marrow
grafts, marrow-derived CTPs must compete with many non-
progenitors for oxygen [6]. While many cells in marrow are
extremely sensitive to conditions in which oxygen tension is
reduced, CTPs may have a competitive advantage over many
non-progenitors in being able to survive under conditions of
low oxygen tension, and to some extent may perform better
under conditions of moderate hypoxia [7,8]. Cell processing to
reduce the number of competing non-progenitors has been
proposed as one possible means of reducing the magnitude
of local hypoxia and improving the survival and performance
of transplanted CTPs. This paper explores the feasibility of an
alternative strategy: augmenting the survival and performance
of CTPs by transplanting cells in an environment in which
oxygen is released slowly from a secondary source, thereby
blunting the rate of decline in oxygen tension. 
© 2013 Heylman et al; licensee Herbert Publications Ltd. Tis is an Open Access article distributed under the terms of Creative Commons Attribution License 
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The presence of erythrocytes (red blood cells or RBCs) within
the site of CTP transplantation is one possible buffer that might
slow the rate of onset of hypoxia. As local oxygen tension
drops within an area in which RBCs are entrapped, oxygen
should be released from the hemoglobin in these cells and
act to buffer the rate of onset of hypoxia [9]. 
This study was therefore designed to address two focused
aims: 1) To test the hypothesis that the presence of RBCs in
the milieu will improve the colony forming efficiency and
performance of CTPs exposed to a rapid onset of hypoxia
in vitro, and 2) To test the hypothesis that delaying the onset
of hypoxia rather than preventing hypoxia will improve the
survival and performance of CTPs in vitro. Additionally, several
different methods for management of a marrow aspirate were 
compared for their relative effectiveness in minimizing CTP
loss, removing non-CTP nucleated cells, and removing RBCs. 
Materials and methods 
Experimental Overview 
A series of in vitro experiments were performed to assess the
effect of variation of oxygen tension, the presence of RBCs,
and changes in processing methods on the colony forming
efficiency of CTPs and the in vitro performance of their progeny.
Fresh heparinized marrow aspirates were collected from
either the proximal humerus in canines, or the human iliac
crest, using established methods, described below. 
Canine Marrow: Aspiration and Bufy Coat Preparation 
Marrow from four canine subjects (female coon hounds,
age 2 to 3 years and weight 35.0 to 40.2 kg) was aspirated
under general anesthesia at the time of euthanasia with
Cleveland Clinic IACUC approval. A Lee-Lok needle (Lee
Medical, Minneapolis, MN) was positioned percutaneously in
the proximal humerus. A series of 2 cc aspirates were taken
from the hematopoietic marrow in cancellous intramedullary
space of the proximal humerus, repositioning the needle
between aspirations. Samples were immediately diluted
and anticoagulated by mixing with 1 cc of heparinized
saline (1000 IU/ml) (APP Pharmaceuticals, LLC, Schaumburg,
IL). Marrow aspirates were pooled and centrifuged at 400
x g for 10 minutes. The buffy coat cells were resuspended
in 20 ml α-MEM medium containing 0.3% bovine serum
albumin (Sigma Aldrich, St. Louis, MO) and 2U/ml heparin
and centrifuged to again isolate a buffy coat. Peripheral
blood (25 cc) was also obtained by percutaneous aspiration
from the jugular vein, and immediately mixed with 1 cc of
heparinized saline (1000 U/ml). 
Human Marrow Donors: Aspiration and Bufy Coat
Preparation 
Bone marrow was aspirated from the iliac crest of 24 patients
(12 female and 12 male, age 25 to 76) undergoing elective
hip or knee arthroplasty procedures in an IRB approved
protocol with informed consent. Under sterile conditions, an
11 gauge aspiration needle (Lee-Lok, Minneapolis, MN) was
advanced into the intramedullary cavity of the anterior iliac
crest through a 3 mm stab incision. Peripheral blood (25 ml)
was also aspirated from a peripheral upper extremity vein at
the time of intravenous needle placement. Unless otherwise
noted below, aspiration and processing methods were exactly 
as described above for canine samples [10]. 
In Vitro CTP Assay 
All samples were cultured in an Ex Vivo Incubator (Biospherix,
Ltd., Redfield, NY). Nucleated cells were plated at a density of
106 cells/well in 12 well, flat bottom culture plates (Corning®
Costar®, Lowell, MA) or in 2 well Lab-Tek™ Chamber Slides™
(Nalge Nunc International, Rochester, NY). Osteogenic media
was used comprising: α-MEM media, 10% fetal bovine serum,
(Cambrex, Walkersville, MD), sodium ascorbate (50ug/ml)
(Sigma Aldrich, St. Louis, MO), 1% antibiotic/antimycotic
(Gibco, Grand Island, NY), and 10-8 M dexamethasone (Sigma
Aldrich, St. Louis, MO) as described in previous publications
[8,11]. All media was pre-equilibrated to the defined oxygen
tension before media changes. 
Image Capture and Analysis of Cells and Colonies 
Cell nuclei and alkaline phosphatase activity were detected
in fluorescent images that were captured and processed
as described by Powell, et al., [12]. The Colonyze™ image
analysis software was used as previously described to assess
the observed prevalence of CTPs [Obs PCTP], defined as the
number of CTPs per million nucleated cells plated [13], and
the median number of cells per colony [8,11,12] for each
condition. The colony forming efficiency of each condition
was calculated by standardizing the Obs P  to the Obs PCTP CTP 
of the control condition for each experiment (CFE = [Obs PCTP] 
 / [Obs P ] ). These methods are compliant withCONDITION CTP CONTROL
the recently published ASTM standard method for automated
colony analysis [14]. 
Efect of the rate of oxygen tension decline on CTP
colony forming efciency and proliferation 
Cells from the buffy coat of nine human marrow samples
were obtained. Samples were plated at a density of 106 cells
per Lab-Tek™ chamber (4.2 cm2) (Nalge Nunc International,
Rochester, NY). Media was changed on days 2 and 3. Samples
were exposed to incubator controlled oxygen tensions that
declined linearly from 21% O2 to 0.1% O2 over varied time
intervals (0 (immediate drop), 6, 12, 24, 48, or 96 hours) using
an Ex Vivo Incubator (Biospherix, Ltd., Redfield, NY) and then
remained at 0.1% O2 (Supplement Figure S1). On Day 6, cultures 
were fixed with 1:1 acetone:methanol for 10 minutes and
stained for nuclei with 4’,6-diamidino-2-phenylindole (DAPI)
(Vector Labs, Burlingame, CA) and VECTOR® Red alkaline
phosphatase substrate (Vector Labs, Burlingame, CA) to
confirm early osteogenic differentiation of CTPs and their
progeny for image analysis using Colonyze™ [12]. 
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Efect of co-culture with RBCs in mitigating the efect
of hypoxia on CTPs 
Canine marrow-derived nucleated cells were plated at a density
of 106 cells per well (3.8 cm2) in 12 well, flat bottom culture
dishes (Corning® Costar®, Lowell, MA). Peripheral blood was
centrifuged at 1000 x g for 5 minutes. Plasma and buffy coat
fractions were removed. The lower portion of the remaining
packed RBC volume was rinsed with α-MEM, centrifuged
again at 1000 x g, and the supernatant removed. RBCs were
added to each culture well in transwell inserts with a pore
size of 0.4 um (Millipore, Billerica, MA). RBCs were added in a
volume equivalent to the approximate average adult human
hematocrit (40% of the total medium volume) [15]. Starting
from the post-processing condition in which all cells and media
were equilibrated to ambient atmospheric oxygen tension
(21%), samples were placed into one of three different oxygen
tension conditions: 3% O2 (physiologic), 0.1% O2 (hypoxic), or a 
“48 hr Decline” in oxygen tension (i.e., an incubator controlled
linear decline from 21% O2 to 0.1% O2 over 48 hours, followed
by a constant 0.1% O2). This last condition mimics the decline
in oxygen tension that has been reported in a bone defect [4]. 
RBCs were only added in conditions of a 48 hour decline to
mimic the in vivo wound environment. A 48 hour decline also
takes advantage of RBC’s oxygen-dependent oxygen binding
properties. RBCs are expected to slowly release oxygen at a
rate proportional to the rate of the slowly declining oxygen
environment.  CO2 levels for all conditions were maintained
at 5%. A medium change on day 4 was performed in an O2 
controlled workspace as appropriate at 3 or 0.1% O2. Cultures
were harvested on day 6. Cells adherent to the bottom of the
chamber were fixed in acetone:methanol (1:1, v/v) and stained 
with DAPI (Vector Labs, Burlingame, CA) to detect nuclei and
with VECTOR® Red alkaline phosphatase substrate (Vector Labs, 
Burlingame, CA) to confirm early osteogenic differentiation
of CTPs for analysis using Colonyze™ [12]. 
Efect of direct contact with RBCs on CTP colony
forming efciency
Six human samples were used. RBCs were removed from
the pooled marrow samples using ammonium chloride lysis
methods described below. RBCs were added back to the
nucleated cell samples at concentrations of 0%, 50%, and
100% of the RBC concentration in the initial marrow aspirate.
Cells were cultured for 9 days with a medium change on day
7. Colonies consisting of eight cells or more were counted on
a bright field microscope.
Comparison of methods for processing a bone marrow
aspirate 
Seven different methods for management of a human marrow 
aspirate were compared for their relative effectiveness
in preserving total observed CTPs (minimizing CTP loss),
removing non-CTP nucleated cells, and removing RBCs: Marrow
aspirate alone, buffy coat separation, 1:1 dilution with saline,
each of these first three with Lymphoprep™ separation, or
ammonium chloride lysis.
Ammonium Chloride Lysis 
Starting with a double buffy coat sample (3-5 ml), 0.155M
NH4Cl (Fisher Scientific, Pittsburgh, PA) was added in equal
volume and vortexed at 2,800 rpm for 3 min with the intention 
of lysing RBCs while preserving other nucleated cells, including
CTPs. An equal volume of 2X PBS + 5% bovine serum albumin
(Sigma Aldrich, St. Louis, MO) was then added to the lysis
solution and vortexed for an additional 5 min at 2,800 rpm
to halt lysis by restoring an isotonic environment. Cells were
rinsed once with PBS and resuspended in α-MEM medium
containing 0.3% bovine serum albumin (Sigma Aldrich, St.
Louis, MO). 
The viability of the remaining nucleated cells from both the
NH4Cl and buffy coat RBC removal techniques was confirmed
to be greater than 99% based on Trypan blue exclusion.
Samples were plated at 5 x 105 nucleated cells per 9.6 cm2 
well in six-well culture plates (Costar, Cambridge, MA). Cells
were cultured in osteogenic medium at 37°C, 5% CO2, and
20% O2 in a humidified incubator for 9 days with a medium
change on day 7. Colonies consisting of eight cells or more
were manually counted using a bright field microscope. 
Lymphoprep™ Separation 
Lymphoprep™ is an isosmotic medium with a density of 1.077
g/ml that allows RBCs and polymorphonuclear leukocytes to
sediment through the medium while retaining mononuclear
cells at the sample/medium interface [4]. Density gradient
separation using Lymphoprep™ (Axis-Shield, Oslo, Norway)
was evaluated using marrow from four human subjects (N=4).
Three methods of preprocessing the starting sample were
compared: whole marrow, 1:1 dilution of marrow using isotonic
saline, and a buffy coat preparation. 6 ml of each sample was
layered over 3 ml of Lymphoprep™ in a 15 ml Falcon tube. 
All three samples (whole, diluted, and buffy coated) were
spun in an Allegra 6 Beckman Coulter centrifuge (Beckman
Coulter, Brea, CA) at 800 x g for 30 minutes at room temperature.
Four fractions were collected after centrifugation. The top
fatty layer, the cell layer, and the red blood cell layer were
each separated. In addition, the few cells remaining in the
serum and Lymphoprep™ solution layers were pooled for
analysis. Each fraction was diluted with 10 ml of media and
centrifuged for 10 minutes at 229 x g to remove the remaining
Lymphoprep™ solution. 
Samples from each of these 4 fractions were stained with
Trypan blue (Sigma Aldrich, St. Louis, MO) for viability, placed
in 0.3% acetic acid to lyse any residual RBCs, and counted
with a hemocytometer. All fractions were cultured under
osteogenic medium conditions at a plating density of 1,25,000 
cells per cm2 in Lab-Tek™ chamber slides (4.2 cm2) (Nalge Nunc
International, Rochester, NY) with medium changes on Days
2 and 3. Day 6 cultures were fixed with 1:1 acetone:methanol
4 
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Figure 1. Te Efect of the Rate of Decline in Oxygen on the CFE of Human CTPs: Te fuorescent micrographs represent 
each of the 6 conditions tested. Te large micrograph within each condition is a large feld of view fuorescent image of an 
entire 4.2 cm2 LabTek chamber with colonies detected by Colonyze™ circled. Te smaller micrographs are fuorescent images of 
representative individual colonies stained for DAPI and alkaline phosphatase (ALP). 
for 10 minutes and stained for nuclei (DAPI).
Statistical Analysis 
All comparisons between variables were initially performed
using a one-way analysis of variance with a significance
of α=0.05. Post-hoc analysis was performed on significant
variables with multiple comparisons using the Tukey-Kramer
test. Error bars indicating a 95% confidence interval were
reported for each standardized condition to allow for visual
comparison between conditions. Lack of overlap of error
bars indicates a difference between two conditions with a
significance of α=0.05. 
Results 
Efect of the rate of oxygen tension decline on CTP
colony forming efciency and proliferation 
Figure 1 shows micrographs of the large field of view image
of an entire LabTek chamber with the colonies detected
by Colonyze™ analysis. Also included are zoom images of
a representative colony from each chamber stained with
DAPI and alkaline phosphatase demonstrating the ability
of CTPs and their progeny to proliferate and differentiate
down an osteogenic pathway. Figure 2 illustrates the rCFE for
samples cultured under each of the oxygen decline conditions 
illustrated in Supplement Figure S1. Data for each subject
are standardized to the Obs PCTP with an oxygen decline of
0 hours. A 3-fold improvement in rCFE was observed when
the onset of hypoxia was delayed over 96 hours (mean rCFE
: 3.0; 95% CI 1.45, 4.57). Figure 3 illustrates that no significant
change in mean cells per colony was observed for any of
the conditions defined in Supplement Figure S1. The area
fraction of alkaline phosphatase (AFALP) was calculated for
each condition of oxygen tension decline, where AFALP = 
area (# of pixels) of ALP fluorescence/total colony area*100.
These data demonstrated no significant change in AFALP 
among colonies generated under various ramp conditions.
The mean AFALP for 0, 6, 12, 24, 48, and 96 hour declines were
0.89±4.0, 0.78±3.1, 0.67±2.3, 0.65±3.3, 1.2±4.4, and 2.4±8.2,
(mean±SD), respectively.
Efect of co-culture with RBCs in mitigating the efect
of hypoxia on CTPs 
Figure 4 illustrates the rCFE for samples from four subjects.
The Obs P  for each subject is standardized to the Obs PCTP CTP 
cultured under continuous 3% O2 to obtain the rCFE. Immediate
onset of hypoxia, 0.1% O2, resulted in a 44% reduction in rCFE
when compared to culture at 3% O2 (mean rCFE: 0.56; 95% CI:
0.432, 0.686 (p=0.005)). A delay in onset of hypoxia over 48
hours resulted in an rCFE equivalent to that at 3% O2 (mean
rCFE: 0.89; 95% CI: 0.767, 1.003 (p=0.399)). rCFE was decreased
Heylman et al. Journal of Regenerative Medicine & Tissue Engineering  2013, 
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Figure 2. Te Efect of the Rate of Decline in Oxygen on the 
CFE of Human CTPs: Te data represent the mean with 95% 
confdence interval for rCFE for each condition (N=9). A 
single asterisk (‘*’) denotes a signifcant diference in rCFE 
from the 0, 6, 24, and 48 hour conditions with p<0.05. 
Figure 3. Te Efect of the Rate of Decline in Oxygen on the 
Proliferation of Human CTPs: Te data represent the mean 
with 95% confdence interval for rCFE for each condition 
(N=9). 
Figure 4. Te Efect of RBCs and Slowed Oxygen Decline on 
the CFE of Canine CTPs: Te data represent the mean with 
95% confdence interval for rCFE for each condition (N=4). 
A single asterisk (‘*’) denotes a signifcant diference from all 
other conditions (p<0.05). A double asterisk (‘**’) denotes a 
signifcant diference from ‘3% O2 ’, ’48 hr O2 Decline’, and ’48 
hr O2 Decline + RBC, No Marrow’ (p<0.05). 
Figure 5. Te Efect of Increased RBC Concentrations on 
the CFE of Human CTPs: Te data represent the mean 
with 95% confdence interval for rCFE for each condition 
(N=6). Peripheral blood alone contained little to no CTPs 
(data not shown). A single asterisk (‘*’) denotes a signifcant 
diference from ‘MNC’ (p<0.05). 
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significantly when RBCs were co-cultured with CTPs despite
the protection of the delayed O2 decline (mean rCFE: 0.22;
95% CI: 0.053, 0.391 (p=<0.001)). Plating only the 100% RBC
aliquot without marrow confirmed that the RBC fraction from
peripheral blood contains only rare CTPs.
Efect of direct contact with RBCs on CTP colony
forming efciency 
Figure 5 illustrates that addition of RBCs to cultures of
mononuclear cells (MNCs) decreases CFE in a dose-dependent
fashion. Data for rCFE in the 50% and 100% add back groups
are standardized to the MNC alone condition. rCFE was not
affected by returning 50% of RBCs to the sample (mean=
0.87; 95% CI: 0.511, 1.229 (p=0.803)). Return of RBCs to 100%
of the original RBC count caused a 47%% decrease in rCFE
(mean = 0.53; 95% CI: 0.189, 0.850 (p=0.021)).
Comparison of methods for RBC Removal 
Figure 6 summarizes the effect of each RBC removal method
with respect to total CTPs retained, nucleated cells retained,
CTP prevalence, and efficacy of RBC removal for 4 human
marrow samples. A single buffy coat caused depletion of 51%
+/- 12% of total nucleated cells and 76% +/- 10% of RBCs in
the sample, but provided the best retention of CTPs (89%
+/- 33%) from the initial sample, and also increased the Obs
5 
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Figure 6. Summary of RBC Removal Methods and Results: All RBC removal methods began with 
whole marrow and underwent the steps indicated by arrows. Removal methods are numbered 1-4 and 
ranked by the number of CTPs remaining, CTP prevalence, and remaining concentration of RBCs 
relative to whole marrow. Data summarizing the relative yield of cells (rCells), CTPs (rCTP), RBCs 
(rRBC) is provided for each method.  Tese data are normalized to the initial number of cells, CTPs, 
and RBCs in the starting whole marrow sample.  Te fold change in P  (ΔP ) is also provided, CTP CTP
again normalized to the PCTP in whole marrow. 
PCTP in the sample by 1.7 fold +/- 0.88. Direct Lymphoprep™
processing maximally depleted RBCs (98.5% +/- 12%) and
nucleated cells 81% +/- 23%, but only preserved 41% +/- 51%
of the CTPs in the initial sample and increased Obs PCTP by
over two fold (2.2 +/- 1.7). Ammonium chloride lysis resulted
in the cleanest sample with the fewest remaining RBCs, but
retained only 74% +/- 34% of the CTPs. Detailed results are
presented in the Supplement Figures S2, S3, S4 and S5. 
Discussion 
Survival and colony formation by transplanted connective
tissue progenitor cells (CTPs) are important factors in the
success of clinical tissue engineering strategies for bone
regeneration. In defects larger than a few millimeters, CTPs
are transplanted into a detrimentally hypoxic environment.
This study tested the hypothesis that delaying the onset of
hypoxia will improve the survival and performance of CTPs
in vitro. The potential value of local red blood cells (RBCs) as
a buffer of oxygen levels was also assessed. 
This study was limited in scope to focus on the behavior of
CTPs in an environment mimicking a bone defect. Experiments 
were performed in vitro using freshly harvested bone tissue
and peripheral blood samples in osteogenic medium and
with changing oxygen levels simulating a diffusion-limited
avascular bone defect. This in vitro model does not simulate
inflammatory effects, or the infiltration of tissue resident cells
and their competition with transplanted CTPs for oxygen
and other nutrients. 
The presence of RBCs does not protect CTPs from hypoxia.
These data further suggest that RBCs have a toxic effect on
CTPs in vitro. Regardless of whether RBCs were added in a
transwell chamber (not in direct contact with CTPs) or placed
in co-culture (in direct contact with CTPs), rCFE was reduced
in the presence of RBCs. The fact that reduced rCFE correlates
with the mere presence of RBCs in the same medium as
CTPs, and not the direct contact of RBCs and CTPs, suggests
that soluble factors may contribute to this negative effect
[16]. Though it is unclear which soluble factors mediate this
effect, limiting the number of RBCs in a wound site may be
beneficial to CTP survival and subsequent healing. There
are also theoretical reasons, beyond the in vitro studies
performed here, to limit RBC contamination in sites of CTP
transplantation in vivo. In the setting of a fracture hematoma
or a post-operative wound site, the deposition of RBCs is
inevitably followed by the release of RBC contents (mostly
hemoglobin) into the local tissues. This contributes to the
inflammatory process and increases the subsequent influx
of monocytes and macrophages, increasing local metabolic
demand, and further decreasing local oxygen levels until
revascularization is complete. 
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CTPs exhibited increased rCFE when the linear decline of
oxygen from 21% O2 to 0.1% O2 was slowed to occur over
96 hours. rCFE improved 3-fold (95% CI: 1.45, 4.57) when
compared to an immediate exposure to a 0.1% O2 environment.
These findings support the initial hypothesis that the survival
and performance of bone marrow-derived CTPs are sensitive
to the rate of onset of hypoxia. This observation raises the
possibility of designing in vivo methods to delay the onset
of hypoxia in clinical settings as a means of improving
the survival and performance of transplanted CTPs. CFE,
proliferation, migration, and differentiation of colony founding 
CTPs and their progeny has been shown to vary with oxygen
tension [7,8]. Optimal colony forming efficiency has been
reported in the range of 2-5% O2 [7,8,17-20]. However, several
investigators have demonstrated that colony formation and
proliferation can still be observed at levels of O2 tension
as low as 0.1% [7,8]. This suggests that at least a subset of
CTPs may be relatively resistant to rapid onset of hypoxia.
The fact that CFE was seen to increase when the onset of
hypoxia was delayed suggests that many colony founding
CTPs can be recovered if sufficient time is made available for
adaptation to hypoxic conditions [21]. Several authors have
proposed that adaptation of bone marrow-derived stem
and progenitor cells, by either brief conditioning exposure
to hypoxia or a gradual onset of hypoxia, may have longer-
term pro-survival effects in vivo [22,23]. Several reports have
described methods by which oxygen can be delivered into
a local wound environment [24-27]. However, given the
large oxygen demand of respiring cells, these methods are
generally limited to the support of a relatively small number
of cells for a relatively short period of time (days) [24-26]. 
The implication of the findings of this study is that the time
required for oxygen delivery to support CTP adaptation may
be on the order of only a few days. Modulation or damping
of the decline of oxygen tension rather than the ongoing
support of maximal metabolic demand may be sufficient
to preserve a functional population of transplanted CTPs in
a wound site long enough for revascularization to provide
the mass transport system needed for new tissue formation. 
In the RBC removal techniques presented, buffy coat proved
to be most effective in preserving CTP yield (89 +/- 33%).
Lymphoprep™ separation was associated with a loss of 50-
70% of the CTP colony forming activity when compared to
unprocessed marrow. These findings suggest that gradient
separation methods, while valuable in the preparation of
“clean”, RBC free samples of nucleated cell populations, may
confound analysis through the inadvertent loss of CTPs. The
value of RBC free samples must be balanced with the risk of
CTP loss. 
These data provide insight into methods that may be used
to improve the sampling, processing, and assay conditions
designed to measure the true prevalence of CTPs in bone
marrow. Optimal assays of CTP prevalence should maximize
CTP preservation and colony forming efficiency. Traditionally,
doi: 10.7243/2050-1218-2-7 
the measure of the true prevalence of CTPs in bone marrow
has been assayed by culture at 21% oxygen [10,11,28-31]. 
Many groups have shown that lower oxygen concentrations
(1%-7% oxygen) yield greater survival and performance for
cells taken from the marrow space [18,21-23,32]. While rapid
onset of hypoxia (0.1% O2) is compatible with colony formation
by some CTPs, rCFE drops by 40% when compared to 3% O2. 
Based on these data, we propose that the preferred method
for assay of CTP prevalence is using buffy coat isolation of
nucleated cells and culture at 3% O2. 
Conclusions 
In aggregate, the data presented suggest that cellular therapies
using freshly isolated marrow-derived CTPs may be enhanced
by defining means of delaying the rapid onset of hypoxia in
the transplantation environment. These data also suggest
the need for further optimization of methods to reduce RBC
contamination at the site of implantation while minimizing
the inadvertent loss of CTPs during cell processing steps. 
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